ArticleFrontiers in immunology2026

Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach.

Afif Nakhleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.